Speetzen Michael T 4
4 · Polaris Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Polaris (PII) CEO Michael Speetzen Receives Equity Award
What Happened
- Michael T. Speetzen, CEO of Polaris Inc. (PII), received equity awards on January 28, 2026. The filing reports two components: 65,446 shares acquired at $64.94 per share (total value reported $4,250,063) and a derivative award for 243,275 shares recorded at $0.00.
- These transactions are grants/awards (transaction code A), not open-market purchases or sales—i.e., compensation-related equity, not an outright stock buy or sale.
Key Details
- Transaction date: 2026-01-28. Filing date: 2026-01-30 (timely; Form 4 generally must be filed within two business days).
- Awarded shares: 65,446 shares at $64.94 (reported value $4,250,063). Derivative award: 243,275 shares @ $0.00 (reported as derivative/option).
- Vesting note (footnote F1): the derivative option vests in three equal installments on Feb 9, 2027; Feb 8, 2028; and Feb 13, 2029.
- Shares owned after the transaction: not provided in the data you supplied (check the full Form 4 for post-transaction beneficial ownership).
- No indication in this filing that shares were sold or that a 10b5-1 plan or tax withholding was used.
Context
- This is a grant of compensation equity (one cash-valued share award and a larger derivative/options award with future vesting). Such grants are common for executives and reflect compensation decisions rather than immediate trading intent.
- Because the larger portion is a derivative award that vests over time, its economic benefit depends on future vesting and Polaris’s share price at those vesting dates.
Insider Transaction Report
Form 4
Polaris Inc.PII
Transactions
- Award
Common Stock
2026-01-28$64.94/sh+65,446$4,250,063→ 188,117 total - Award
Employee Stock Option (right to buy)
[F1]2026-01-28+243,275→ 243,275 totalExercise: $71.43Exp: 2036-01-28→ Common Stock (243,275 underlying)
Footnotes (1)
- [F1]The option vests in three equal installments on February 9, 2027, February 8, 2028, and February 13, 2029.
Signature
/s/ Sarah Maveus, as attorney-in-fact|2026-01-30